Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0OQ8Q
|
|||
| Drug Name |
Vatiquinone
|
|||
| Synonyms |
alpha-Tocotrienol quinone; UNII-6O85FK9I0X; 1213269-98-7; 6O85FK9I0X; Vatiquinone [USAN:INN]; Vatiquinone (JAN/USAN); SCHEMBL503125; (R)-Alpha-Tocotrienol Quinone; CHEMBL1812161; SCHEMBL14639355; DTXSID90153231; LNOVHERIIMJMDG-XZXLULOTSA-N; DB11917; 2,5-Cyclohexadiene-1,4-dione, 2-((3R,6e,10E)-3-hydroxy-3,7,11,15-tetramethyl-6,10,14-hexadecatrien-1-yl)-3,5,6-trimethyl-; D10407
Click to Show/Hide
|
|||
| Indication | Friedreich's ataxia [ICD-11: 8A03.10; ICD-9: 334] | Phase 2 | [1] | |
| Company |
Edison Pharmaceuticals Mountain View, CA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C29H44O3
|
|||
| Canonical SMILES |
CC1=C(C(=O)C(=C(C1=O)C)CCC(C)(CCC=C(C)CCC=C(C)CCC=C(C)C)O)C
|
|||
| InChI |
1S/C29H44O3/c1-20(2)12-9-13-21(3)14-10-15-22(4)16-11-18-29(8,32)19-17-26-25(7)27(30)23(5)24(6)28(26)31/h12,14,16,32H,9-11,13,15,17-19H2,1-8H3/b21-14+,22-16+/t29-/m1/s1
|
|||
| InChIKey |
LNOVHERIIMJMDG-XZXLULOTSA-N
|
|||
| CAS Number |
CAS 1213269-98-7
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.